Home/Pipeline/mRNA-based Influenza Vaccine

mRNA-based Influenza Vaccine

Seasonal Influenza

Phase 3ActiveN/A

Key Facts

Indication

Seasonal Influenza

Phase

Phase 3

Status

Active

Company

Sanofi

About Sanofi

Sanofi is a global biopharmaceutical leader with a mission to 'chase the miracles of science' by developing innovative medicines and vaccines. The company has strategically pivoted to become an R&D-driven, AI-powered organization, focusing its deep immunoscience expertise on high-growth areas like immunology and oncology. Its strategy is centered on accelerating drug discovery, optimizing its robust pipeline, and delivering compelling growth through breakthrough therapeutics.

View full company profile

Therapeutic Areas

Immunology Oncology Rare Diseases Neurology Vaccines

Other Seasonal Influenza Drugs

Drug	Company	Phase	Status
mRNA-1010/1011	Moderna	Phase 3	Active
Standalone Seasonal Influenza Vaccine	Novavax	Phase 3	Active
LUNAR®-FLU (ARCT-2138)	Arcturus Therapeutics	Phase 1	Status Unknown
Oral Influenza Vaccine	Vaxart	Phase 2	Active